The recent gambling legislation approved by Congress and sanctioned by President Lula emphasizes the importance of responsible gaming, establishing strict measures to prevent compulsive behaviors and protect vulnerable groups that may lead to Ludopathy.
Ludriq is introduced to integrate with operators' systems and comply with current legislation, considering the prohibition of participation by individuals diagnosed with this disorder characterized by a compulsion for gambling. The tool comprises a set of questions developed by medical professionals to identify risky behaviors. By integrating this solution, the betting platform can identify players capable of participating responsibly.
According to the company, the Previneo API is fast, simple, secure, and extremely easy to integrate, allowing obtaining health information about the population and integrating it into any system. This enables saving lives and conserving resources through prevention and early diagnosis.
"We are available to conduct a personalized demonstration, showing how Ludriq can be efficiently incorporated into your platform," the company states on its social media.
The Previneo platform uses artificial intelligence following major medical guidelines to prevent and diagnose chronic diseases, such as cancer, through a user-friendly and simple interface. In addition to providing a personalized action plan for the user and accompanying them in the primary health care system, it offers managers access to real-time data. This allows monitoring the population and making decisions based on accurate information.
Previneo is the first Brazilian startup to apply artificial intelligence algorithms to identify potential health risks and save lives. Founded in 2015, Previneo has served over 85,000 people in more than 20 companies across Brazil, democratizing access to health and revolutionizing prevention.
Based on well-founded and registered medical criteria, Previneo's 'Healthcare Suite' uses artificial intelligence to identify people at risk of developing various health-related risks, including cancer, respiratory diseases, cardiovascular issues, and mental health problems.
The startup won the Roche™M Challenge in 2019 and will participate in an immersion program at Roche Diagnostics' Digital Health Accelerator in Munich, Germany.
Source: GMB
